Conavi Medical Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024
Net Income	-16.19	-20.52	-43.62
Depreciation & Amortization	0.72	0.51	0.53
Stock-Based Compensation	0.61	0.44	0.26
Other Adjustments	-1.86	-2.64	17.9
Change in Receivables	0.34	0.69	0.06
Changes in Inventories	0.03	1.27	1.39
Changes in Accounts Payable	-0.02	-4.84	2.45
Changes in Income Taxes Payable	0.01	0	0.02
Changes in Unearned Revenue	-0.03	0.47	-0.22
Changes in Other Operating Activities	-2.26	-0.79	0.63
Operating Cash Flow	-20.62	-25.1	-20.15
Capital Expenditures	-0.07	-0.07	-0.58
Purchases of Intangible Assets	-0.26	-0.11	-0.27
Other Investing Activities	1.88	3.75	-
Investing Cash Flow	-0.29	3.57	-0.85
Long-Term Debt Issued	-	-	8.19
Long-Term Debt Repaid	-0.59	-0.55	-0.62
Net Long-Term Debt Issued (Repaid)	-0.59	-0.55	7.58
Issuance of Common Stock	4.98	28.47	0.01
Net Common Stock Issued (Repurchased)	4.98	28.47	0.01
Other Financing Activities	-1	-0.98	-0.32
Financing Cash Flow	16.79	26.94	7.26
Net Cash Flow	-4.12	5.41	-13.73
Free Cash Flow	-20.7	-25.17	-20.72
FCF Margin	-2931.44%	-275.96%	-958.95%
Free Cash Flow Per Share	-	-0.44	-3.36
Levered Free Cash Flow	-22.74	-13	-5.13
Unlevered Free Cash Flow	-16.67	-23.29	-22.01

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.